Caxton Associates LP
- SEC CIK
- 0000872573
- Latest filing
- Feb 14, 2025
HALO holding history
Halozyme Therapeutics, Inc. in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HALO overviewAll 13F holders of HALOFull Q4 2024 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −34,432−100.0% | Sold out | Holders |
| Q3 2024 | 34,432 | $1.97M | 0.1% | +9,000+35.4% | Added | Holders |
| Q2 2024 | 25,432 | $1.33M | 0.1% | +25,432 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −8,281−100.0% | Sold out | Holders |
| Q4 2023 | 8,281 | $306.1K | <0.1% | +8,281 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −13,035−100.0% | Sold out | Holders |
| Q1 2023 | 13,035 | $497.8K | 0.1% | +13,035 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −9,782−100.0% | Sold out | Holders |
| Q2 2022 | 9,782 | $430.0K | 0.1% | +9,782 | New | Holders |